News Nov 18, 2024 Alimentiv Partners on a New Alcoholic Hepatitis Phase 1b Clinical Trial September 2024 – Alimentiv is proud to partner on an exciting new Phase 1b clinical trial in severe alcohol-associated hepatitis, an area with high mortality… Read Now
Interview Jul 19, 2024 Expanding the Alimentiv Site Network: An Interview With Peter Westerveld The Alimentiv Site Network (ASN) is our worldwide network of gastrointestinal (GI) centers that collaborate with us. With an established global reputation for high-quality monitoring… Read Now
Publication Jun 16, 2017 Pharmacokinetic drug evaluation of budesonide in the treatment of Crohn’s disease Read Now
Publication Jun 9, 2017 Development of a core outcome set for clinical trials in inflammatory bowel disease: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey Read Now
Publication Jun 8, 2017 A comparison of approaches for adjudicating outcomes in clinical trials Read Now
Publication Jun 1, 2017 Randomised non-inferiority trial: 1600 mg versus 400 mg tablets of mesalazine for the treatment of mild-to-moderate ulcerative colitis Read Now
Publication May 27, 2017 Histologic scoring indices for evaluation of disease activity in ulcerative colitis Read Now
Publication May 10, 2017 The Evolution of Treatment Paradigms in Crohn’s Disease: Beyond Better Drugs Read Now
